UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Operating income declines at top 10 biotechs on KOSDAQ
by Nam Doo-hyun
2018-11-22 11:15
Celltrion CEO involved in alleged ‘gapjil’ scandal
by Lee Han-soo
2018-11-21 16:02
US data crucial for Korean biosimilars after success in Europe
by Nam Doo-hyun
2018-11-21 15:29
FDA OKs sale of Celltrion's HIV biosimilar
by Lee Han-soo
2018-11-21 12:57
Intron Bio inks ₩750 billion licensing deal for anti-superbug drug
by So Jae-hyeon
2018-11-20 15:00
라인
Celltrion Healthcare presents research results on using biosimilars in Europe
by Lee Han-soo
2018-11-19 16:57
Bridge Bio applies for idiopathic pulmonary fibrosis treatment in US
by Lee Han-soo
2018-11-19 11:58
Tego Science sales plunge in Q3
by Lee Han-soo
2018-11-16 14:54
NIBEC wins patent for novel peptide in US
by Lee Han-soo
2018-11-16 14:40
Samsung BioLogics fiasco hardly affects biotech stocks
by Nam Doo-hyun
2018-11-16 11:30
라인
Medipost mark profit losses in Q3
by Lee Han-soo
2018-11-15 15:18
[News Focus] Biotechs to suffer shocks from Samsung BioLogics mess
by So Jae-hyeon
2018-11-15 14:56
Celltrion Healthcare posts ₩212.7 billion in Q3 sales
by Lee Han-soo
2018-11-15 12:43
Regulators suspend trading of Samsung BioLogics on accounting fraud charges
by Lee Han-soo
2018-11-14 18:28
Alteogen promote antibody-drug conjugate cancer treatment in US
by Lee Han-soo
2018-11-14 16:59
라인
GCAM opens new plasma collection centers in US
by Lee Han-soo
2018-11-09 17:58
GC launches Biocon’s antidiabetic biosimilar
by Lee Han-soo
2018-11-08 15:46
'Biosimilar makers to benefit from new research accounting guideline'
by Nam Doo-hyun
2018-11-07 11:23
Biois seeks KOSDAQ listing with ‘technology exception policy’
by So Jae-hyeon
2018-11-06 15:43
Market caps of top 20 drugmakers on KOSPI surged this year
by Nam Doo-hyun
2018-11-06 15:41
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top